Please login to the form below

Not currently logged in
Email:
Password:

Novimmune

This page shows the latest Novimmune news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi

Sobi gained the PRV during the acquisition of Novimmune’s Gamifant (emapalumab) related business  earlier this year.

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Sosei appoints CFO Sosei appoints CFO

    Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

  • Novimmune appoints Guillaume de Sampaïo Novimmune appoints Guillaume de Sampaïo

    Prior to joining Novimmune he served at Danish biotech firm Forward Pharma, where he created and managed its clinical development group. ... Guillaume de Sampaïo will help us to further advance Novimmune as we move closer to the market with our lead

  • Novimmune expands senior management team Novimmune expands senior management team

    Fleurant joins Novimmune with 20 years of quality expertise in life sciences, most recently having served as head of quality affairs at Alvotech, an Icelandic biosimilars specialist. ... Eduard Holdener, chairman and chief executive of Novimmune, said:

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics